209 related articles for article (PubMed ID: 30600674)
1. Natural Course and Risk of Cholangiocarcinoma in Patients with Recurrent Pyogenic Cholangitis: A Retrospective Cohort Study.
You MS; Lee SH; Kang J; Choi YH; Choi JH; Shin BS; Huh G; Paik WH; Ryu JK; Kim YT; Jang DK; Lee JK
Gut Liver; 2019 May; 13(3):373-379. PubMed ID: 30600674
[TBL] [Abstract][Full Text] [Related]
2. Comparison of concomitant and subsequent cholangiocarcinomas associated with hepatolithiasis: Clinical implications.
Lin CC; Lin PY; Chen YL
World J Gastroenterol; 2013 Jan; 19(3):375-80. PubMed ID: 23372360
[TBL] [Abstract][Full Text] [Related]
3. Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD.
Gulamhusein AF; Eaton JE; Tabibian JH; Atkinson EJ; Juran BD; Lazaridis KN
Am J Gastroenterol; 2016 May; 111(5):705-11. PubMed ID: 27002801
[TBL] [Abstract][Full Text] [Related]
4. Association of Endoscopic Sphincterotomy or Papillary Balloon Dilatation and Biliary Cancer: A Population-Based Cohort Study.
Peng YC; Lin CL; Hsu WY; Chow WK; Lee SW; Yeh HZ; Chang CS; Kao CH
Medicine (Baltimore); 2015 Jun; 94(23):e926. PubMed ID: 26061315
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of long-term results and recurrent factors after operative and nonoperative treatment for hepatolithiasis.
Cheon YK; Cho YD; Moon JH; Lee JS; Shim CS
Surgery; 2009 Nov; 146(5):843-53. PubMed ID: 19744434
[TBL] [Abstract][Full Text] [Related]
6. Recurrent pyogenic cholangitis - an independent poor prognostic indicator for resectable intrahepatic cholangiocarcinoma: A propensity score matched analysis.
Ma KW; Cheung TT; She WH; Chok KSH; Yan Chan AC; Chiu Dai JW; Lo CM
HPB (Oxford); 2018 Nov; 20(11):1067-1072. PubMed ID: 30017784
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors for Cholangiocarcinoma After Initial Hepatectomy for Intrahepatic Stones.
Meng ZW; Han SH; Zhu JH; Zhou LY; Chen YL
World J Surg; 2017 Mar; 41(3):835-843. PubMed ID: 27766397
[TBL] [Abstract][Full Text] [Related]
8. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
[TBL] [Abstract][Full Text] [Related]
9. CT findings of cholangiocarcinoma associated with recurrent pyogenic cholangitis.
Kim JH; Kim TK; Eun HW; Byun JY; Lee MG; Ha HK; Auh YH
AJR Am J Roentgenol; 2006 Dec; 187(6):1571-7. PubMed ID: 17114552
[TBL] [Abstract][Full Text] [Related]
10. Surgical management decreases disease recurrence risk in recurrent pyogenic cholangitis.
Tan HL; Koh YX; Lye WK; Lee SY; Goh BKP; Tan SS; Chiow AKH; Chan CY
ANZ J Surg; 2018 Sep; 88(9):E659-E663. PubMed ID: 29228512
[TBL] [Abstract][Full Text] [Related]
11. Is pyogenic liver abscess associated with recurrent pyogenic cholangitis a distinct clinical entity? A retrospective analysis over a 10-year period in a regional hospital.
Law ST; Li KK
Eur J Gastroenterol Hepatol; 2011 Sep; 23(9):770-7. PubMed ID: 21716118
[TBL] [Abstract][Full Text] [Related]
12. A combination of liver fluke infection and traditional northeastern Thai foods associated with cholangiocarcinoma development.
Sriraj P; Boonmars T; Aukkanimart R; Songsri J; Sripan P; Ratanasuwan P; Boonjaraspinyo S; Wongchalee N; Laummaunwai P
Parasitol Res; 2016 Oct; 115(10):3843-52. PubMed ID: 27271702
[TBL] [Abstract][Full Text] [Related]
13. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.
Chalasani N; Baluyut A; Ismail A; Zaman A; Sood G; Ghalib R; McCashland TM; Reddy KR; Zervos X; Anbari MA; Hoen H
Hepatology; 2000 Jan; 31(1):7-11. PubMed ID: 10613720
[TBL] [Abstract][Full Text] [Related]
14. Precancerous Lesions and Liver Atrophy as Risk Factors for Hepatolithiasis-Related Death after Liver Resection for Hepatolithiasis.
Miyazaki T; Shinkawa H; Takemura S; Tanaka S; Amano R; Kimura K; Ohira G; Nishio K; Kinoshita M; Tsuchi J; Ishihara A; Eguchi S; Shirai D; Yamamoto T; Wakasa K; Kawada N; Kubo S
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3647-3654. PubMed ID: 33369464
[TBL] [Abstract][Full Text] [Related]
15. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of repeat hepatic resection for patients with recurrent intrahepatic cholangiocarcinoma: Factors associated with long-term outcomes.
Si A; Li J; Xing X; Lei Z; Xia Y; Yan Z; Wang K; Shi L; Shen F
Surgery; 2017 Apr; 161(4):897-908. PubMed ID: 27989605
[TBL] [Abstract][Full Text] [Related]
17. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
Burak K; Angulo P; Pasha TM; Egan K; Petz J; Lindor KD
Am J Gastroenterol; 2004 Mar; 99(3):523-6. PubMed ID: 15056096
[TBL] [Abstract][Full Text] [Related]
18. Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes after liver transplantation.
Facciuto ME; Singh MK; Lubezky N; Selim MA; Robinson D; Kim-Schluger L; Florman S; Ward SC; Thung SN; Fiel M; Schiano TD
Transplantation; 2015 Jan; 99(1):151-7. PubMed ID: 25029385
[TBL] [Abstract][Full Text] [Related]
19. Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma.
Boyd S; Mustonen H; Tenca A; Jokelainen K; Arola J; Färkkilä MA
Scand J Gastroenterol; 2017 Feb; 52(2):242-249. PubMed ID: 27806633
[TBL] [Abstract][Full Text] [Related]
20. Pyogenic liver abscess related to intrahepatic bile duct stones: Difficulties in infectious control and diagnosis of concomitant cholangiocarcinoma.
Shi SH; Feng XN; Wang ZY; Sun K; Xu JF; Kong HS; Zheng SS
J Gastroenterol Hepatol; 2018 May; 33(5):1092-1099. PubMed ID: 28984386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
